The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551).
Bilski AJ, Halliday SE, Fitzgerald JD, Wale JL.
Bilski AJ, et al.
J Cardiovasc Pharmacol. 1983 May-Jun;5(3):430-7. doi: 10.1097/00005344-198305000-00013.
J Cardiovasc Pharmacol. 1983.
PMID: 6191142
Previously described beta 2-selective antagonists such as butoxamine, H 35/25, and IPS 339 are lacking in potency, specificity, or appropriate beta 2-selectivity. ICI 118,551 [erythro-dl-1-(7-methylindan-4-yloxy)-3-isopropylaminobutan-2-ol] possesses a high degree o …
Previously described beta 2-selective antagonists such as butoxamine, H 35/25, and IPS 339 are lacking in potency, specificity …